Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Paul Sabatier University EA- |
RCV000207372 | SCV000259134 | likely benign | Anophthalmia-microphthalmia syndrome | 2013-01-01 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000384797 | SCV000341028 | uncertain significance | not provided | 2016-04-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001086986 | SCV001131934 | likely benign | Cone-rod dystrophy 13; Leber congenital amaurosis 6 | 2024-01-26 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001002218 | SCV001160092 | uncertain significance | not specified | 2018-12-12 | criteria provided, single submitter | clinical testing | The RPGRIP1 c.808A>G; p.Ile270Val variant (rs372615343) is reported in the medical literature in an individual with an ocular development anomaly, but was not determined to be causative (Chassaing 2016). The variant is reported in the ClinVar database (Variation ID: 221937) and in the general population in 50 out of 205878 alleles. The amino acid at this position is moderately conserved across species but computational analyses (SIFT: Tolerated, PolyPhen-2: Probably Damaging) predict conflicting effects of this variant on protein structure/function. Considering available information, the clinical significance of this variant cannot be determined with certainty. References: Chassaing N et al. Targeted resequencing identifies PTCH1 as a major contributor to ocular developmental anomalies and extends the SOX2 regulatory network. Genome Res. 2016 Apr;26(4):474-85. |
Genome- |
RCV001800533 | SCV002045658 | uncertain significance | Leber congenital amaurosis 6 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001800534 | SCV002045756 | uncertain significance | Cone-rod dystrophy 13 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003955239 | SCV004770344 | likely benign | RPGRIP1-related disorder | 2022-05-25 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |